Who is sponsoring NCT04162951?

NCT04162951 is sponsored by Tanta University.

What drugs are being tested in NCT04162951?

Interventions in NCT04162951: Ordinary approach paravertebral block, Retrolaminar paravertebral block.

What condition does NCT04162951 study?

NCT04162951 studies Regional Anesthesia Morbidity, Postoperative Pain.

Is NCT04162951 still recruiting?

NCT04162951 is currently completed. Last updated 24 October 2023.

Last reviewed 2023-10-24 · How we verify

NCT04162951

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Retrolaminar Thoracic Paravertebral Block

Completed NA Last updated 24 October 2023

What this trial tests

NA trial testing Ordinary approach paravertebral block in Regional Anesthesia Morbidity in 93 participants. Completed in 19 October 2023.

Timeline

10 November 2019

Primary endpoint
19 October 2023

19 October 2023

Quick facts

Lead sponsor	Tanta University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	supportive care
Enrollment	93
Start date	10 November 2019
Primary completion	19 October 2023
Estimated completion	19 October 2023
Sites	1 location across Egypt

Drugs / interventions tested

Ordinary approach paravertebral block
Retrolaminar paravertebral block

Conditions studied

Regional Anesthesia Morbidity — all drugs for Regional Anesthesia Morbidity →
Postoperative Pain — all drugs for Postoperative Pain →

Sponsor

Tanta University

Who can join

Adults 40 to 60, female only, with Regional Anesthesia Morbidity or Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical study will be conducted on female patients admitted to The General Surgery Department of Tanta Faculty of Medicine for a period of 9 months. Patients will be randomly allocated into one of the following two groups;- • Ordinary approach group (30 patients): The patients in this group will receive ordinary ultrasound-guided thoracic paravertebral block. • Retro-laminar approach group (30 patients): The patients in this group will be receive real ultrasound-guided Retrolaminar thoracic paravertebral block. All the patients will receive general anesthesia with attachment to a monitor (5 ASA Monitoring) In addition to bispectral index.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Regional Anesthesia Morbidity

Currently open trials in the same condition.

NCT06426706 — TPVB or SPSIPB in Pain Management After VATS · NA · recruiting
NCT06520150 — Evaluation of the Effectiveness of Two Methods of Regional Anesthesia During S-ICD Implantation Procedure. · NA · recruiting
NCT06168903 — EOI Block Versus ESP Block in Laparoscopic Bariatric Surgery · NA · recruiting
NCT05233462 — Height Adjusted Versus Standardized Dose of Bupivacaine for Spinal Anesthesia · NA · recruiting

Other Tanta University trials

Trials by the same sponsor.

NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04162951 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tanta University
Last refreshed: 24 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04162951.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing